Tharimmune Inc

Tharimmune Inc

THAR - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$767.7M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Tharimmune IncTharimmune Inc-1.2--22%--
$0.53

Current Fair Value

85% downside

Overvalued by 85% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$767.70 Million
Enterprise Value$730.46 Million
Earnings per Share$-1.12
Beta1.45
Outstanding Shares216,864,938

Return

Return on Equity-21.57%ROE
Return on Assets-17.38%
Return on Invested Capital-13.49%

Valuation & Multiples

P/E Ratio-1.24P/E Ratio
PEG-0.13PEG
Price to Sales-Price to Sales
Price to Book Ratio1.77Price to Book Ratio
Enterprise Value to Revenue488.32
Enterprise Value to EBIT-9.64
Enterprise Value to Net Income-8
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
June 3, 2026
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Tharimmune Inc

12 employees
CEO: Mark Wendland

Canton Strategic Holdings Inc., which was formerly known as Tharimmune, Inc. until its name change in February 2026, focuses on two primary areas. The company is committed to promoting the institutional integration of blockchain technolo...

Tharimmune Insider Information FAQ

In the latest 13F quarter on Stockcircle, 1 top investor reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.